T-Cell Vaccination in Multiple Sclerosis (MS)
Recruitment status was Recruiting
The purpose of this study is to evaluate the safety of T-cell vaccination in MS patients.
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Educational/Counseling/Training
|Official Title:||The Effect of T-Cell Vaccination in Multiple Sclerosis - Phase I/II Safety and Efficacy Trial|
- safety assessment of T-cell vaccination in nonresponding MS patients
|Study Start Date:||July 1998|
|Estimated Study Completion Date:||December 2007|
Immunization of MS patients with irradiated autologous encephalitogenic myelin peptides (EMP) specific T-cell lines or clones.
Clinical immunologic and neuroradiologic evaluation.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00220428
|Contact: Anat Achiron, MD PhD||972-3-5303932||ACHIRON@POST.TAU.AC.IL|
|Contact: Matilda Mandel, MD||972-3-5305309|
|Multiple Sclerosis Center||Recruiting|
|Ramat Gan, Israel|
|Contact: Anat Achiron, MD PhD 972-3-5303932 Achiron@post.tau.ac.il|
|Contact: Matilda Mandel, MD 972-3-5304081|
|Principal Investigator: Anat Achiron, MD PhD|
|Principal Investigator:||Anat Achiron, MD PhD||Sackler School of Medicine|